Sotos syndrome: genes and variants
Explore variant evidence for Sotos syndrome across 2 analyzed proteins (NSD1, SCN4A). Linked ClinVar records include 83 pathogenic or likely pathogenic variants, 169 variants of uncertain significance and 119 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Sotos syndrome
NSD1: Histone-lysine N-methyltransferase, H3 lysine-36 specific
It regulates developmental transcription through chromatin modification, including H3K36 methylation. Haploinsufficiency causes Sotos syndrome with childhood overgrowth, characteristic facial features, and developmental delay, while somatic rearrangements occur in some leukemias.
82 ClinVar pathogenic / likely pathogenic and 288 uncertain variants in NSD1 have source records linked to Sotos syndrome. Association strength is not clinical gene validity.
SCN4A: Sodium channel protein type 4 subunit alpha
Its rapid sodium current initiates and propagates skeletal-muscle action potentials. Gain- and loss-of-function variants cause disorders of muscle excitability including sodium-channel myotonia, paramyotonia congenita, periodic paralysis, and some congenital myopathies.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SCN4A have source records linked to Sotos syndrome. Association strength is not clinical gene validity.
Where Sotos syndrome variants cluster
- NSD1 SET (positions 1942–2059): 21 of 74 ClinVar pathogenic / likely pathogenic variants, 6.5× more than its size predicts (a length-based count, not a validated hotspot).
- NSD1 PHD-type 4 (positions 2118–2165): 10 of 74 ClinVar pathogenic / likely pathogenic variants, 7.6× more than its size predicts (a length-based count, not a validated hotspot).
- NSD1 PHD-type 2 (positions 1590–1646): 9 of 74 ClinVar pathogenic / likely pathogenic variants, 5.8× more than its size predicts (a length-based count, not a validated hotspot).
- NSD1 AWS (positions 1890–1940): 8 of 74 ClinVar pathogenic / likely pathogenic variants, 5.7× more than its size predicts (a length-based count, not a validated hotspot).
- NSD1 PWWP 2 (positions 1756–1818): 6 of 74 ClinVar pathogenic / likely pathogenic variants, 3.5× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Sotos syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| NSD1 R1914C | 1914 | AWS | Pathogenic / likely pathogenic (★★) |
| NSD1 R1914L | 1914 | AWS | Pathogenic / likely pathogenic (★★) |
| NSD1 R1952W | 1952 | SET | Pathogenic / likely pathogenic (★★) |
| NSD1 I1976T | 1976 | SET | Pathogenic / likely pathogenic (★★) |
| NSD1 R2005Q | 2005 | SET | Pathogenic / likely pathogenic (★★) |
| NSD1 I2007T | 2007 | SET | Pathogenic / likely pathogenic (★★) |
| NSD1 C2183G | 2183 | Pathogenic / likely pathogenic (★★) | |
| NSD1 R1663C | 1663 | Pathogenic / likely pathogenic (★★) | |
| NSD1 H1616R | 1616 | PHD-type 2 | Pathogenic / likely pathogenic (★★) |
| NSD1 C1733F | 1733 | PHD-type 3 | Pathogenic / likely pathogenic (★★) |
| NSD1 G1792E | 1792 | PWWP 2 | Pathogenic / likely pathogenic (★★) |
| NSD1 C1920S | 1920 | AWS | Pathogenic / likely pathogenic (★★) |
| NSD1 Y1997H | 1997 | SET | Pathogenic / likely pathogenic (★★) |
| NSD1 Y1997C | 1997 | SET | Pathogenic / likely pathogenic (★★) |
| NSD1 D2119G | 2119 | PHD-type 4 | Pathogenic / likely pathogenic (★★) |
| NSD1 F2122L | 2122 | PHD-type 4 | Pathogenic / likely pathogenic (★★) |
| NSD1 H2186R | 2186 | Pathogenic / likely pathogenic (★★) | |
| SCN4A T704M | 704 | II | Pathogenic / likely pathogenic (★★) |
| NSD1 R1660C | 1660 | Pathogenic / likely pathogenic (★★) | |
| NSD1 C1606Y | 1606 | PHD-type 2 | Pathogenic / likely pathogenic (★★) |
| NSD1 I1962T | 1962 | SET | Pathogenic / likely pathogenic (★★) |
| NSD1 R1984Q | 1984 | SET | Pathogenic / likely pathogenic (★★) |
| NSD1 R2017W | 2017 | SET | Pathogenic / likely pathogenic (★★) |
| NSD1 N2020S | 2020 | SET | Pathogenic / likely pathogenic (★★) |
| NSD1 K2140E | 2140 | PHD-type 4 | Pathogenic / likely pathogenic (★★) |
| NSD1 R2152Q | 2152 | PHD-type 4 | Pathogenic / likely pathogenic (★★) |
| NSD1 R1778Q | 1778 | PWWP 2 | Pathogenic / likely pathogenic (★★) |
| NSD1 H1365R | 1365 | Pathogenic / likely pathogenic (★★) | |
| NSD1 R1861Q | 1861 | Pathogenic / likely pathogenic (★★) | |
| NSD1 C1619S | 1619 | PHD-type 2 | Pathogenic / likely pathogenic (★) |
| NSD1 C1619G | 1619 | PHD-type 2 | Pathogenic / likely pathogenic (★) |
| NSD1 R1914P | 1914 | AWS | Pathogenic / likely pathogenic (★) |
| NSD1 R1952G | 1952 | SET | Pathogenic / likely pathogenic (★) |
| NSD1 G1973D | 1973 | SET | Pathogenic / likely pathogenic (★) |
| NSD1 G1973V | 1973 | SET | Pathogenic / likely pathogenic (★) |
| NSD1 I1976K | 1976 | SET | Pathogenic / likely pathogenic (★) |
| NSD1 I2007F | 2007 | SET | Pathogenic / likely pathogenic (★) |
| NSD1 H2162P | 2162 | PHD-type 4 | Pathogenic / likely pathogenic (★) |
| NSD1 H2162Q | 2162 | PHD-type 4 | Pathogenic / likely pathogenic (★) |
| NSD1 C1733Y | 1733 | PHD-type 3 | Pathogenic / likely pathogenic (★) |
| NSD1 G1792R | 1792 | PWWP 2 | Pathogenic / likely pathogenic (★) |
| NSD1 N1913S | 1913 | AWS | Pathogenic / likely pathogenic (★) |
| NSD1 C1920R | 1920 | AWS | Pathogenic / likely pathogenic (★) |
| NSD1 G1953V | 1953 | SET | Pathogenic / likely pathogenic (★) |
| NSD1 W1954C | 1954 | SET | Pathogenic / likely pathogenic (★) |
| NSD1 G2010V | 2010 | SET | Pathogenic / likely pathogenic (★) |
| NSD1 C2121Y | 2121 | PHD-type 4 | Pathogenic / likely pathogenic (★) |
| NSD1 C2159Y | 2159 | PHD-type 4 | Pathogenic / likely pathogenic (★) |
| NSD1 R2219H | 2219 | Pathogenic / likely pathogenic (★) | |
| NSD1 G1538R | 1538 | Pathogenic / likely pathogenic (★) | |
| NSD1 H1591Y | 1591 | PHD-type 2 | Pathogenic / likely pathogenic (★) |
| NSD1 C1611R | 1611 | PHD-type 2 | Pathogenic / likely pathogenic (★) |
| NSD1 Y1615S | 1615 | PHD-type 2 | Pathogenic / likely pathogenic (★) |
| NSD1 C1640Y | 1640 | PHD-type 2 | Pathogenic / likely pathogenic (★) |
| NSD1 C1643S | 1643 | PHD-type 2 | Pathogenic / likely pathogenic (★) |
| NSD1 G1656C | 1656 | Pathogenic / likely pathogenic (★) | |
| NSD1 C1674Y | 1674 | Pathogenic / likely pathogenic (★) | |
| NSD1 C1689S | 1689 | Pathogenic / likely pathogenic (★) | |
| NSD1 G1717S | 1717 | PHD-type 3 | Pathogenic / likely pathogenic (★) |
| NSD1 P1726L | 1726 | PHD-type 3 | Pathogenic / likely pathogenic (★) |
Showing 60 of 83.
Uncertain variants prioritized for review in Sotos syndrome
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| NSD1 R1660H | 1660 | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; R1660C at the same position is pathogenic; REVEL 0.918 | |
| NSD1 R1914H | 1914 | AWS | Conflicting reports (★) | +6: 4 other pathogenic changes within 3 positions; R1914L at the same position is pathogenic; REVEL 0.817 |
Which prediction tools work for Sotos syndrome
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- AlphaMissense: 99 out of 100
- CATVariant: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 98 out of 100
- PolyPhen-2: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MutPred: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 91 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 86 out of 100
Same protein, different disease
- Hyperkalemic periodic paralysis also has ClinVar records linked to SCN4A variants; they fall mostly in different places as the Sotos syndrome variants (62 pathogenic / likely pathogenic).
- Paramyotonia congenita of Von Eulenburg also has ClinVar records linked to SCN4A variants; they fall mostly in different places as the Sotos syndrome variants (15 pathogenic / likely pathogenic).
- Potassium-aggravated myotonia also has ClinVar records linked to SCN4A variants; they fall mostly in different places as the Sotos syndrome variants (14 pathogenic / likely pathogenic).
- Hypokalemic periodic paralysis also has ClinVar records linked to SCN4A variants; they fall mostly in different places as the Sotos syndrome variants (11 pathogenic / likely pathogenic).
- Congenital myopathy 22A, classic also has ClinVar records linked to SCN4A variants; they fall mostly in different places as the Sotos syndrome variants (8 pathogenic / likely pathogenic).
Diseases related to Sotos syndrome
- Amyotrophic lateral sclerosis, also linked to SCN4A
- Cardiac arrhythmia, also linked to SCN4A
- Hyperkalemic periodic paralysis, also linked to SCN4A
- Acute myeloid leukemia, also linked to NSD1
- Hypokalemic periodic paralysis, also linked to SCN4A
- Myasthenic syndrome, also linked to SCN4A
- Skeletal muscle channelopathy, also linked to SCN4A
- Epilepsy, also linked to SCN4A
- Paramyotonia congenita of Von Eulenburg, also linked to SCN4A
- Potassium-aggravated myotonia, also linked to SCN4A
- Weaver syndrome, also linked to NSD1
- Congenital myopathy 22A, classic, also linked to SCN4A
Frequently asked questions
Which genes have records linked to Sotos syndrome?
This view contains 2 analyzed proteins: NSD1, SCN4A. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 83 pathogenic or likely pathogenic variants, 169 variants of uncertain significance and 119 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 2 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 509 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center